UA94980C2 - trimetazidine dihydrochloride cardiovascular drug in the form of matrix tablet with prolonged action and processes for preparation thereof (variants) - Google Patents
trimetazidine dihydrochloride cardiovascular drug in the form of matrix tablet with prolonged action and processes for preparation thereof (variants)Info
- Publication number
- UA94980C2 UA94980C2 UAA200907425A UAA200907425A UA94980C2 UA 94980 C2 UA94980 C2 UA 94980C2 UA A200907425 A UAA200907425 A UA A200907425A UA A200907425 A UAA200907425 A UA A200907425A UA 94980 C2 UA94980 C2 UA 94980C2
- Authority
- UA
- Ukraine
- Prior art keywords
- variants
- processes
- preparation
- cardiovascular drug
- prolonged action
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to medicine and chemical-pharmaceutical industry, in particular, to the formation,production and use of cardiovascular drug - trimetazidine dihydrochloride in the form of matrix tablets with controlled release of the drug for 12 and 24 hours.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAA200907425A UA94980C2 (en) | 2009-07-15 | 2009-07-15 | trimetazidine dihydrochloride cardiovascular drug in the form of matrix tablet with prolonged action and processes for preparation thereof (variants) |
PCT/UA2010/000026 WO2011008183A1 (en) | 2009-07-15 | 2010-05-14 | Trimetazidine dihydrochloride-containing medication in the form of an extended-release matrix tablet (variants) and methods for preparing same (variants) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAA200907425A UA94980C2 (en) | 2009-07-15 | 2009-07-15 | trimetazidine dihydrochloride cardiovascular drug in the form of matrix tablet with prolonged action and processes for preparation thereof (variants) |
Publications (1)
Publication Number | Publication Date |
---|---|
UA94980C2 true UA94980C2 (en) | 2011-06-25 |
Family
ID=43449604
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200907425A UA94980C2 (en) | 2009-07-15 | 2009-07-15 | trimetazidine dihydrochloride cardiovascular drug in the form of matrix tablet with prolonged action and processes for preparation thereof (variants) |
Country Status (2)
Country | Link |
---|---|
UA (1) | UA94980C2 (en) |
WO (1) | WO2011008183A1 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1195160E (en) * | 2000-10-05 | 2009-12-07 | Usv Ltd | Sustained release trimetazidine pharmaceutical compositions and a method of their preparation |
UA12297U (en) * | 2005-11-24 | 2006-01-16 | Pharma Start Ltd Liability Com | Matrix tablet providing for delayed release of trimetasin |
RU2362548C1 (en) * | 2007-11-20 | 2009-07-27 | Закрытое Акционерное Общество "Канонфарма Продакшн" | Matrix tablet with basis for trimetazidine dihydrochloride release, way of its reception and way of treatment |
-
2009
- 2009-07-15 UA UAA200907425A patent/UA94980C2/en unknown
-
2010
- 2010-05-14 WO PCT/UA2010/000026 patent/WO2011008183A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2011008183A1 (en) | 2011-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL216522A (en) | Tamper-resistant pharmaceutical dosage form, packaging comprising the same and process for its production | |
TN2011000466A1 (en) | Substituted 2-acetamido -5-aryl-1, 2, 4- triazolones and use thereof | |
TN2012000428A1 (en) | Bisaryl-bonded aryltriazolones and use thereof | |
TW201711676A (en) | Ferric citrate dosage forms | |
IL208832A (en) | 3-aminocarbazole compounds, pharmaceutical compositions containing them, preparation methods thereof and use thereof in the production of drugs | |
TN2012000549A1 (en) | Substituted 5-fluoro-1h-pyrazolopyridines and use thereof | |
WO2009068214A3 (en) | Heteroaryl-substituted piperidines | |
MX343358B (en) | Ulipristal acetate tablets. | |
IL218370A0 (en) | Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen, processes for producing the same and uses thereof | |
IL215826A (en) | Sustained release pharmaceutical composition, process for its preparation, its use for the manufacture of a medicament for the treatment of pain and a tablet comprising it | |
WO2011104652A3 (en) | Veterinary compositions | |
IN2012DN02793A (en) | ||
MX2014012799A (en) | Tablets with coating and the production thereof. | |
TW200745132A (en) | Novel, acyclically substituted furopyrimidine derivatives and use thereof | |
MX2010002506A (en) | Substituted nicotinamide compounds and the use thereof in pharmaceutical products. | |
MX2014012164A (en) | Compositions containing probiotics and a bee pollen/clay complex, preparation method thereof and uses of same in nutrition and therapeutics. | |
IL213671A (en) | Pharmaceutical compositions comprising aleglitazar, process for their manufacture and use thereof in the preparation of medicaments | |
PH12015501377A1 (en) | Solid unit with high fexofenadine content and process for the preparation thereof | |
PH12014502221A1 (en) | Prasugrel-containing immediate release stable oral pharmaceutical compositions | |
WO2011027258A3 (en) | Scented capsules | |
MY166555A (en) | Substituted piperidine | |
MX2013002261A (en) | Substituted n-phenethyltriazoloneacetamides and use thereof. | |
IL213105A (en) | Compounds, a process for the preparation thereof, pharmaceutical compositions comprising them and uses thereof in the manufacture of medicaments | |
GB0615105D0 (en) | Novel compounds | |
UA94980C2 (en) | trimetazidine dihydrochloride cardiovascular drug in the form of matrix tablet with prolonged action and processes for preparation thereof (variants) |